TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32960145

Group type: EXPERIMENTAL
Intervention: Vigorous-intensity physical activity (VPA)
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Moderate physical activity (MPA)
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Vigorous-intensity physical activity (VPA) in ≥1-min bouts
Number of subjects: 169
Study: 35685760

Group type: EXPERIMENTAL
Intervention: WhatsApp group (n = 41)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Electronic brochures group (n = 41)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Both intervention groups
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: WhatsApp group
Number of subjects: 121
Study: 34272042

Group type: EXPERIMENTAL
Intervention: IABP support
Number of subjects: 217

Group type: COMPARATOR
Intervention: No IABP support
Number of subjects: 217
Study: 35297108

Group type: EXPERIMENTAL
Intervention: Fixed-dose combination Cal/BD foam (calcipotriol 50 µg/g and betamethasone dipropionate 0.5 mg/g) for 4 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fixed-dose combination Cal/BD foam (calcipotriol 50 µg/g and betamethasone dipropionate 0.5 mg/g)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fixed-dose combination Cal/BD foam
Number of subjects: 0
Study: 36367563

Group type: EXPERIMENTAL
Intervention: Oncokompas
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 58
Study: 34034339

Group type: EXPERIMENTAL
Intervention: Automated testing in quiet
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Automated testing in noise
Number of subjects: 26

Group type: COMPARATOR
Intervention: Standard audiometry
Number of subjects: 26
Study: 33849632

Group type: EXPERIMENTAL
Intervention: Sharp debridement with needle insertion
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Physiological saline water injection
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Lidocaine injection
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conservative sharp debridement only
Number of subjects: 40
Study: 35597698

Group type: EXPERIMENTAL
Intervention: VMAT(vDIBH)
Number of subjects: 21

Group type: COMPARATOR
Intervention: WT(vDIBH)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 21
Study: 32304555

Group type: EXPERIMENTAL
Intervention: CO2 insufflation
Number of subjects: 178

Group type: COMPARATOR
Intervention: Air insufflation
Number of subjects: 178
Study: 35726054

Group type: EXPERIMENTAL
Intervention: N-back working memory training
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: Untrained N-back tasks performance
Number of subjects: 460
Study: 33152672

Group type: EXPERIMENTAL
Intervention: CTH intervention
Number of subjects: 67
Study: 35976752

Group type: EXPERIMENTAL
Intervention: Preoperative online intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (non-online intervention)
Number of subjects: 0
Study: 32812021

Group type: EXPERIMENTAL
Intervention: Cervical headgear
Number of subjects: 40

Group type: COMPARATOR
Intervention: Elastic separators
Number of subjects: 40
Study: 34592318

Group type: EXPERIMENTAL
Intervention: tPA bolus (50 mg tPA IV bolus followed by 7 days of heparin)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: tPA drip (50 mg tPA IV bolus, followed by tPA drip 2 mg/h plus heparin 500 units/h over 24 h)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (standard‐of‐care treatment)
Number of subjects: 50
Study: 33038815

Group type: EXPERIMENTAL
Intervention: Momentary assessment (Experience Sampling Method)
Number of subjects: 24
Study: 34392331

Group type: EXPERIMENTAL
Intervention: Sacubitril-valsartan
Number of subjects: 731

Group type: COMPARATOR
Intervention: Valsartan
Number of subjects: 731
Study: 32276452

Group type: EXPERIMENTAL
Intervention: Post-Activation Performance Enhancement (PAPE)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (CONT)
Number of subjects: 12
Study: 35119373

Group type: EXPERIMENTAL
Intervention: Smartphone-based data collection (weekly surveys, audio recordings, and passive location data)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Smartphone-based data collection (passively collected location data)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Cox regression analysis
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Data completeness
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Data completeness over time
Number of subjects: 49
Study: 34111416

Group type: EXPERIMENTAL
Intervention: Metronomic capecitabine (650 mg/m2 body surface area twice daily for 1 year)
Number of subjects: 406

Group type: COMPARATOR
Intervention: Standard therapy (observation)
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: Metronomic capecitabine
Number of subjects: 406

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 406
Study: 35695863

Group type: EXPERIMENTAL
Intervention: Gefitinib treatment
Number of subjects: 282

Group type: COMPARATOR
Intervention: Inhibition of β-catenin
Number of subjects: 282
Study: 32951870

Group type: EXPERIMENTAL
Intervention: Conventional posterior palatal seal
Number of subjects: 0

Group type: COMPARATOR
Intervention: Arbitrary posterior palatal seal
Number of subjects: 0
Study: 36305661

Group type: EXPERIMENTAL
Intervention: Ureteroscopy (URS) for urolithiasis
Number of subjects: 166
Study: 33466627

Group type: EXPERIMENTAL
Intervention: 600 mg of sage combination (CogniviaTM)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study: 32079999

Group type: EXPERIMENTAL
Intervention: Empathetic interaction
Number of subjects: 68

Group type: COMPARATOR
Intervention: Neutral interaction
Number of subjects: 68
Study: 35608600

Group type: EXPERIMENTAL
Intervention: Subcutaneous casirivimab and imdevimab antibody combination
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32663179

Group type: EXPERIMENTAL
Intervention: Complementary and integrative medicine
Number of subjects: 556

Group type: EXPERIMENTAL
Intervention: Overall exercise, massage, and melatonin
Number of subjects: 556

Group type: EXPERIMENTAL
Intervention: Prospective randomized controlled trials
Number of subjects: 556

Group type: EXPERIMENTAL
Intervention: Personal experience
Number of subjects: 556
Study: 35567836

Group type: EXPERIMENTAL
Intervention: Medium dose corticosteroids
Number of subjects: 23

Group type: COMPARATOR
Intervention: Low dose corticosteroids
Number of subjects: 23

Group type: COMPARATOR
Intervention: High dose corticosteroids
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: All dosing regimens
Number of subjects: 23
Study: 34628738

Group type: EXPERIMENTAL
Intervention: ZHU Lian's typeⅡ inhibition acupuncture
Number of subjects: 120

Group type: COMPARATOR
Intervention: Flunarizine hydrochloride capsule, 5 mg once a day
Number of subjects: 120
Study: 32125178

Group type: EXPERIMENTAL
Intervention: Insulin glargine 300 U/mL (Gla-300)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Insulin degludec 100 U/mL (Deg-100)
Number of subjects: 100
Study: 32893707

Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser with tranexamic acid (TA)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Microneedling with tranexamic acid (TA)
Number of subjects: 30
Study: 34487442

Group type: EXPERIMENTAL
Intervention: Cannabinoid-based medicines
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36251861

Group type: EXPERIMENTAL
Intervention: Full-body interaction cognitive training (FBI-CT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Tablet-based cognitive training (T-CT)
Number of subjects: 20
Study: 33671161

Group type: EXPERIMENTAL
Intervention: Supportive management
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Sense of cohesion
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Working as a coping strategy
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: High demands and lack of acceptance
Number of subjects: 98
Study: 36428227

Group type: EXPERIMENTAL
Intervention: Sumac supplementation (500 mg, twice a day for 6 weeks)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo (lactose, twice a day for 6 weeks)
Number of subjects: 47
Study: 34446475

Group type: EXPERIMENTAL
Intervention: Transient 100% oxygen administration
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ingestion of a standardised mixed meal
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: CBmeter data analysis
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (20 participants)
Number of subjects: 40
Study: 32297122

Group type: EXPERIMENTAL
Intervention: Job‐Based Social Skills (JOBSS) curriculum, a manualized, 15‐week, group‐delivered intervention
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Job‐Based Social Skills (JOBSS) curriculum
Number of subjects: 22

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 22
Study: 36098905

Group type: EXPERIMENTAL
Intervention: ClearfilTMS3Bond Plus (CSB)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: ClearfilTMSE Protect Bond (CSEPB)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Prime&Bond®XP (PBXP)
Number of subjects: 34
Study: 33952557

Group type: EXPERIMENTAL
Intervention: Hypertonic saline (HS) nose drops (2.6% sodium chloride), three drops/nostril, at least four times a day, until 24 hours after asymptomatic or a maximum of 28 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard symptomatic care
Number of subjects: 0
Study: 32683106

Group type: EXPERIMENTAL
Intervention: Combined exercise training (12 weeks, resistance, endurance, Pilates, balance, and stretch exercises, performed 3 days/week)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Control (waitlist control)
Number of subjects: 94
Study: 35042290

Group type: EXPERIMENTAL
Intervention: CT model constructed using radiomic label, pleural depression, and quantitative parameters (diameter, average density)
Number of subjects: 352

Group type: COMPARATOR
Intervention: Morphological model
Number of subjects: 352

Group type: COMPARATOR
Intervention: Comprehensive model
Number of subjects: 352
Study: 34813369

Group type: EXPERIMENTAL
Intervention: Fresh mangos
Number of subjects: 23

Group type: COMPARATOR
Intervention: Isocaloric low-fat cookies
Number of subjects: 23
Study: 34429446

Group type: EXPERIMENTAL
Intervention: Microbial larvicide VectoMax (Bacillus thuringiensis var israelensis and Bacillus sphaericus) applied every 2 weeks in standing water collection points
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Microbial larvicide VectoMax
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (non-intervention area)
Number of subjects: 26
Study: 33927333

Group type: EXPERIMENTAL
Intervention: Whole-body electromyostimulation with exercise training (WB-EMSG)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Sham control group (ShamG)
Number of subjects: 35
Study: 32236442

Group type: EXPERIMENTAL
Intervention: Exercise plus nap
Number of subjects: 115

Group type: COMPARATOR
Intervention: Nap only
Number of subjects: 115

Group type: COMPARATOR
Intervention: Exercise only
Number of subjects: 115
Study: 35616352

Group type: EXPERIMENTAL
Intervention: Individualized care (EG)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Routine care (CG)
Number of subjects: 120
Study: 33440330

Group type: EXPERIMENTAL
Intervention: Pelvic binder placement
Number of subjects: 43

Group type: COMPARATOR
Intervention: Usual care (non-binder)
Number of subjects: 43
Study: 32867226

Group type: EXPERIMENTAL
Intervention: Low glycemic index (LGI) diet plan (n = 40)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Usual diet (Control group, n = 40)
Number of subjects: 80
Study: 35219761

Group type: EXPERIMENTAL
Intervention: Non-insulin treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Insulin treatment
Number of subjects: 0
Study: 34777714

Group type: EXPERIMENTAL
Intervention: Brief behavioural intervention for psychological distress
Number of subjects: 410

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 410
Study: 32403259

Group type: EXPERIMENTAL
Intervention: EXP-120 g/h
Number of subjects: 20

Group type: COMPARATOR
Intervention: CON-90 g/h
Number of subjects: 20

Group type: COMPARATOR
Intervention: LOW-60 g/h
Number of subjects: 20
Study: 35776749

Group type: EXPERIMENTAL
Intervention: Statistical models adjusting for exposure time, covariates, and data augmentation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Safety endpoint analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Raw data examination
Number of subjects: 0
Study: 32976346

Group type: EXPERIMENTAL
Intervention: Direct drive hearing aid with wider bandwidth
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Direct drive hearing aid with 123 Hz cut-off
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Full-band conditions
Number of subjects: 15
Study: 33771833

Group type: EXPERIMENTAL
Intervention: MyREADY Transition TM BBD App
Number of subjects: 264

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 264
Study: 33177756

Group type: EXPERIMENTAL
Intervention: Community health worker providing supplementary hypertension‐oriented care including proteinuria assessment by visual assessment of urinary dipstick at the first visit and all subsequent visits when hypertension was detected.
Number of subjects: 30233

Group type: EXPERIMENTAL
Intervention: Projected annual cost savings if proteinuria testing were restricted to women with hypertension.
Number of subjects: 30233
Study: 36346619

Group type: EXPERIMENTAL
Intervention: Type 2 diabetes
Number of subjects: 38

Group type: COMPARATOR
Intervention: Non-diabetic (ND)
Number of subjects: 38
Study: 33546490

Group type: EXPERIMENTAL
Intervention: Front-of-pack nutrition labelling (FOP-NL) systems
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Easy-to-interpret FOP-NL
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Educational campaigns
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Monitoring strategy
Number of subjects: 0
Study: 32365109

Group type: EXPERIMENTAL
Intervention: Negative mood induction
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Positive mood induction
Number of subjects: 165

Group type: COMPARATOR
Intervention: Neutral mood induction
Number of subjects: 165
Study: 34992099

Group type: EXPERIMENTAL
Intervention: Informational SRH text messages on-demand
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Weekly texts instructing to study SRH topics
Number of subjects: 740

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 740
Study: 34561781

Group type: EXPERIMENTAL
Intervention: Wearing a surgical mask
Number of subjects: 6

Group type: COMPARATOR
Intervention: Not wearing a surgical mask (unmasked)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Wearing a surgical mask (sensitivity analysis)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Not wearing a surgical mask (unmasked, sensitivity analysis)
Number of subjects: 6
Study: 35067753

Group type: EXPERIMENTAL
Intervention: FO + D (fish oil plus vitamin D3)
Number of subjects: 111

Group type: COMPARATOR
Intervention: FO (fish oil)
Number of subjects: 111

Group type: COMPARATOR
Intervention: CO (corn oil)
Number of subjects: 111
Study: 32437191

Group type: EXPERIMENTAL
Intervention: Structured Dyadic Behavior Therapy (SDBT)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Attention Control (Child-Centered Dyadic Therapy - CCDT)
Number of subjects: 34
Study: 32006071

Group type: EXPERIMENTAL
Intervention: Informational flipchart on pelvic floor muscle training (PFMT) and lifestyle advice
Number of subjects: 140

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 140
Study: 34560315

Group type: EXPERIMENTAL
Intervention: 1 mg/kg of 0.25% levobupivacaine with 5 µg/mL epinephrine
Number of subjects: 24

Group type: COMPARATOR
Intervention: 1 mg/kg of 0.25% levobupivacaine alone
Number of subjects: 24
Study: 34520324

Group type: EXPERIMENTAL
Intervention: Music intervention
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 74
Study: 33865010

Group type: EXPERIMENTAL
Intervention: Cognitive stimulation program (10 sessions of 45 min for 10 weeks)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Cognitive stimulation program
Number of subjects: 29
Study: 32239091

Group type: EXPERIMENTAL
Intervention: CA125
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: HE4
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: ROMA index
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: IHC markers
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: CA125 and HE4
Number of subjects: 92
Study: 33852140

Group type: EXPERIMENTAL
Intervention: Evidence-based intervention
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Education/training
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Practice facilitation
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: IS/QI elements
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Randomized designs
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Complexity of projects
Number of subjects: 99
Study: 32581042

Group type: EXPERIMENTAL
Intervention: Nivolumab followed by ipilimumab (Checkmate-064)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Nivolumab (Checkmate-066)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Nivolumab, ipilimumab, or both (Checkmate-067)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Chemotherapy (Checkmate-064)
Number of subjects: 3
Study: 34384772

Group type: EXPERIMENTAL
Intervention: 1-step GDM screening
Number of subjects: 23792

Group type: COMPARATOR
Intervention: 2-step GDM screening
Number of subjects: 23792
Study: 32998110

Group type: EXPERIMENTAL
Intervention: 30-min session of moderate-intensity aerobic exercise
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (watched a running/exercise-related video)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Acute aerobic exercise in children with LD
Number of subjects: 100
Study: 34491805

Group type: EXPERIMENTAL
Intervention: SCTA01 (5 mg/kg)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: SCTA01 (15 mg/kg)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: SCTA01 (30 mg/kg)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: SCTA01 (50 mg/kg)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: SCTA01 (5 to 50 mg/kg)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: SCTA01
Number of subjects: 33
Study: 32769744

Group type: EXPERIMENTAL
Intervention: Inferior mesenteric artery low ligation
Number of subjects: 168

Group type: COMPARATOR
Intervention: Inferior mesenteric artery preservation
Number of subjects: 168
Study: 34546187

Group type: EXPERIMENTAL
Intervention: Surgery performed less than 7 days after fracture
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Closed reduction and percutaneous pinning performed more than 7 days after injury
Number of subjects: 184
Study: 34340251

Group type: EXPERIMENTAL
Intervention: suvorexant 10-20 mg
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: suvorexant
Number of subjects: 285

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 285
Study: 34371813

Group type: EXPERIMENTAL
Intervention: CS‐RT+CrM (n = 8)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: CS‐RT (n = 8)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (n = 7)
Number of subjects: 23
Study: 32346816

Group type: EXPERIMENTAL
Intervention: Paper-based EQ-5D-5L
Number of subjects: 0

Group type: COMPARATOR
Intervention: Electronic modes (handheld, tablet, IVR, web)
Number of subjects: 0
Study: 35810600

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Preference match
Number of subjects: 226
Study: 34464973

Group type: EXPERIMENTAL
Intervention: Thiotepa-based immunochemotherapy (TIER) regimen including thiotepa 50 mg/m2, ifosfamide, etoposide, and rituximab for 2 cycles.
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Thiotepa-based immunochemotherapy (TIER) followed by autologous stem cell transplantation (ASCT) consolidation.
Number of subjects: 27
Study: 32162949

Group type: EXPERIMENTAL
Intervention: Male officer using force
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: Female officer using force
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: Officers using force
Number of subjects: 452

Group type: COMPARATOR
Intervention: Officers not using force
Number of subjects: 452
Study: 33946024

Group type: EXPERIMENTAL
Intervention: Lateral stair walking training + traditional physiotherapy (15 min each)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Traditional physiotherapy (30 min)
Number of subjects: 24
Study: 32187079

Group type: EXPERIMENTAL
Intervention: Superiority trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Equivalence trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methodological differences
Number of subjects: 0
Study: 35174789

Group type: EXPERIMENTAL
Intervention: Grade 4 hemorrhoids patients
Number of subjects: 51

Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 51
Study: 34016554

Group type: EXPERIMENTAL
Intervention: Preoperative carbohydrate loading (2 carbohydrate drinks: 1 the night before and another 3 hours prior to surgery)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Standard management (nothing by mouth after midnight prior to surgery)
Number of subjects: 134
Study: 32383146

Group type: EXPERIMENTAL
Intervention: Grape seed extract (GSE) at 10 g kg‐1
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Grape seed extract (GSE) at 50 g kg‐1
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (0 g kg‐1 GSE)
Number of subjects: 90
Study: 35471480

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH)
Number of subjects: 123
Study: 35191331

Group type: EXPERIMENTAL
Intervention: Case-management rehabilitation intervention
Number of subjects: 151

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 151
Study: 33486496

Group type: EXPERIMENTAL
Intervention: Methylprednisolone for 7 days
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group (no methylprednisolone)
Number of subjects: 86
Study: 33203008

Group type: EXPERIMENTAL
Intervention: FiberBind
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: RG‐I
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control
Number of subjects: 18